News
VK2735 shows strong early weight loss data, positioning Viking Therapeutics as a potential third major player in the booming GLP-1 obesity drug market. Learn more on VKTX stock here.
The firm hopes that ETX-636's dual mechanism inhibiting mutant PI3Kα will give it an edge over competing products on the market.
Regeneron, playing catch up with J&J and Pfizer, wins FDA approval for Lynozyfic in multiple myeloma
Another BCMA-targeted agent has arrived for the treatment of multiple myeloma. | After a delay, Regeneron’s BCMA-directed ...
PaulAntill pits the brand-new Insta360 X5 against his longtime favorite, the DJI Osmo Pocket 3, to see which one deserves to be the ultimate travel camera. From low light performance and gimbal ...
Get free TV by watching over-the-air channels. Here are our recommendations for the best indoor TV antennas for 2025.
Other major upgrades include a more breathable upper that’s made of a single layer of breathable mesh, a grippier outsole, and even more cushioning in a slightly lighter design. Another pro: The ...
Recent FDA decisions added new options for dermatologists involved in treating patients with psoriasis, bullous pemphigoid ...
Dyson is raising the bar (and the price) with the announcement of its newest Airwrap.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results